Literature DB >> 6252825

Neuropathy and mitochondrial myopathy.

J M Peyronnard, L Charron, A Bellavance, L Marchand.   

Abstract

It has been stated that peripheral neuropathy can be a feature of so-called ophthalmoplegia-plus syndrome, but to date only one case of hypertrophic neuropathy has been reported. This study is concerned with the clinical, electrophysiological, and pathological observations in a 37-year-old man with progressive external ophthalmoplegia and a ragged-red fiber myopathy associated with severe sensorimotor neuropathy. Histological and morphometric studies of the sural nerve revealed a marked loss of large myelinated fibers and an occasional degenerating axon. Residual fibers had disproportionately thin myelin sheaths in relation to axon calibers. In contrast to the muscle biopsy findings, no mitochondrial paracrystalline inclusions were observed in the nerve. However, the number of mitochondria per square micron of Schwann cell cytoplasm was elevated when compared with values obtained from normal subjects and a patient with a chronic neuropathy. These findings may indicate an alteration of mitochondrial function common to muscle fibers and Schwann cells which, in nerves, could lead to axon loss and abnormality of myelination.

Entities:  

Mesh:

Year:  1980        PMID: 6252825     DOI: 10.1002/ana.410070310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine.

Authors:  L D Lewis; F M Hamzeh; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 2.  Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.

Authors:  Bruce H Cohen
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

3.  Metabolism, mitochondrial uptake and toxicity of 2', 3'-dideoxycytidine.

Authors:  L Rossi; S Serafini; G F Schiavano; A Casabianca; G Vallanti; L Chiarantini; M Magnani
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

4.  Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation.

Authors:  H Hara; Y Wakayama; Y Kouno; H Yamada; M Tanaka; T Ozawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

Review 5.  Mitochondrial myopathies. Clinical, morphological and biochemical aspects.

Authors:  R C Sengers; A M Stadhouders; J M Trijbels
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

6.  Mitochondrial cytopathy. A multisystem disorder with ragged red fibres on muscle biopsy.

Authors:  J Egger; B D Lake; J Wilson
Journal:  Arch Dis Child       Date:  1981-10       Impact factor: 3.791

Review 7.  Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy, hereditary and non-hereditary neuropathies, and review of the literature.

Authors:  J M Schröder; C Sommer
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Peripheral neuropathy in patients with CPEO associated with single and multiple mtDNA deletions.

Authors:  Diana Lehmann; Malte E Kornhuber; Carolina Clajus; Charlotte L Alston; Andreas Wienke; Marcus Deschauer; Robert W Taylor; Stephan Zierz
Journal:  Neurol Genet       Date:  2016-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.